Investor
Column Group LLC
CIK 0001833486 · filed 2026-02-13 · SEC filing
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Surrozen, Inc. | — | 1.85M | $41.8M | 50.5% | — | Held |
| Oric Pharmaceuticals, Inc. | ORIC | 3.54M | $29M | 35.0% | — | Held |
| Tenaya Therapeutics, Inc. | TNYA | 9.4M | $6.69M | 8.1% | — | Held |
| Rapt Therapeutics Inc | — | 156.3K | $5.29M | 6.4% | — | Held |
| Revolution Medicines Inc | — | 46 | $3.66K | 0.0% | — | Held |
Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.